CELLTRION, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180,900 KRW | +0.72% |
|
-3.26% | -10.22% |
| May. 24 | Celltrion Receives European Commission Approval of Omlyclo® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe | CI |
| May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
Quotes 5-day view
End-of-day quote Korea S.E.| 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-27 | 2024-05-28 | |
|---|---|---|---|---|---|
| Last | 184800 ₩ | 183500 ₩ | 179900 ₩ | 179600 ₩ | 180900 ₩ |
| Volume | 310 558 | 289 295 | 487 217 | 401 269 | 411 965 |
| Change | -0.75% | -0.70% | -1.96% | -0.17% | +0.72% |
| Opening | 186,500.00 | 183,800.00 | 182,600.00 | 180,600.00 | 179,600.00 |
| High | 188,000.00 | 185,500.00 | 183,800.00 | 181,200.00 | 182,400.00 |
| Low | 184,200.00 | 183,500.00 | 179,600.00 | 178,500.00 | 178,500.00 |
Performance
| 1 day | +0.72% | ||
| 1 week | -3.26% | ||
| Current month | -4.29% | ||
| 1 month | +2.43% | ||
| 3 months | -4.84% | ||
| 6 months | +11.12% | ||
| Current year | -10.22% | ||
| 1 year | +4.51% | ||
| 3 years | -28.66% | ||
| 5 years | +18.12% | ||
| 10 years | +408.52% |
Volumes
marketsDaily volume
411 965
Avg. Volume 20 sessions
527 098
Avg. Volume 20 sessions KRW
95 352 028 200.00
Avg. Volume 20 sessions USD
70 083 740.73
Record volume 1
30 681 116
Record volume 2
17 672 300
Record volume 3
17 648 239
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
36 962 078 032 653
Capitalization (USD)
27 167 127 354
Net sales (KRW)
2 176
Net sales (USD)
2
Number of employees
2 034
Sales / Employee (KRW)
1
Sales / Employee (USD)
0
Free-Float
66.01 %
Free-Float capitalization (KRW)
25 502 352 020 620
Free-Float capitalization (USD)
18 744 228 735
Average Daily Capital Traded
0.26%
Highs and lows
1 week
178 500.00
188 000.00
1 month
178 500.00197 000.00
Current year
169 700.00241 000.00
1 year
131 000.00241 000.00
3 years
131 000.00283 276.77
5 years
121 026.29372 915.00
10 years
27 751.54372 915.00
Indicators
Moving average 5 days
181 740.00
Moving average 20 days
187 275.00
Moving average 50 days
183 842.00
Moving average 100 days
185 531.00
Price spread / (MMA5)
+0.46%
Price spread / (MMA20)
+3.52%
Price spread / (MMA50)
+1.63%
Price spread / (MMA100)
+2.56%
STIM
RSI 9 days
37.94
RSI 14 days
43.63
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.72% | -3.26% | -10.22% | +4.51% | 27.17B | ||
| -8.05% | +8.64% | +54.05% | +21.36% | 63.85B | ||
| -1.26% | -1.47% | -2.02% | +13.67% | 41.83B | ||
| -3.43% | -6.42% | +40.01% | -13.43% | 40.47B | ||
| +0.11% | +0.73% | +13.42% | +57.62% | 26.52B | ||
| +1.56% | -0.12% | -21.60% | -20.29% | 18.69B | ||
| -1.73% | -3.77% | +2.89% | -4.92% | 12.73B | ||
| -1.37% | -2.01% | +22.40% | +29.82% | 12.11B | ||
| +0.07% | -1.62% | +27.49% | +92.00% | 12.07B | ||
| -1.24% | -3.83% | -9.26% | +10.50% | 11.19B | ||
| -1.62% | -5.39% | -3.92% | -9.42% | 9.7B | ||
| -1.91% | -6.51% | +30.31% | -9.41% | 7.08B | ||
| -0.44% | -1.82% | +10.97% | +77.25% | 6.44B | ||
| -0.13% | -5.32% | +32.15% | +47.99% | 6.26B | ||
| -1.14% | -6.35% | -0.49% | -34.06% | 6.18B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | -1.24% | -0.32% | +12.41% | +17.55% | ||
| Weighted average by Cap. | -2.42% | +3.96% | +18.66% | +15.28% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -10.22% | ||
| 2023 | +25.55% | ||
| 2022 | -15.70% | ||
| 2021 | -43.74% | ||
| 2020 | +102.31% | ||
| 2019 | -14.58% | ||
| 2018 | +2.65% | ||
| 2017 | +109.98% | ||
| 2016 | +33.46% | ||
| 2015 | +124.03% | ||
| 2014 | +6.37% | ||
| 2013 | -24.33% | ||
| 2012 | +24.03% | ||
| 2011 | +8.36% | ||
| 2010 | +123.33% | ||
| 2009 | +51.52% | ||
| 2008 | -16.46% |
- Stock Market
- Equities
- A068270 Stock
- Quotes Celltrion, Inc.
